Nabsys and Indiana University Collaborate to Advance Electronic Genome Mapping Applications in Hematologic Malignancies

Nabsys and Indiana University Collaborate to Advance Electronic Genome Mapping Applications in Hematologic Malignancies

PR Newswire

PROVIDENCE, R.I., July 31, 2026

Multi-year research collaboration will focus initially on AML and MDS while advancing Electronic Genome Mapping for broader hematologic research applicationsPROVIDENCE, R.I., July 31, 2026 /PRNewswire/ -- Nabsys 2.0, LLC ("Nabsys"), a pioneer in electronic genome mapping (EGM) technology, today announced a multi-year research collaboration with the Indiana University School of Medicine to develop and evaluate Electronic Genome Mapping applications for hematologic malignancies. As part of the collaboration, Kevin T.A. Booth, Ph.D., FACMG, Assistant Professor, Department of Medical and Molecular Genetics, Indiana University School of Medicine, and Clinical Laboratory Director, Indiana University Genetic Testing Laboratories, will evaluate the OhmX™ Platform to support the development and assessment of Electronic Genome Mapping applications, initially focused on acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), with the potential to extend to additional hematologic malignancies and constitutional disorders over time.